Stock listing

NASDAQ:GRCE Grace Therapeutics, Inc. Stock

Home listing (NASDAQ) of Grace Therapeutics, Inc.

Follow Grace Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:GRCE

$1.88 USD -0.01 (-0.5%)

Close on Oct 19, 2026

Since Jul 6, 2026 -25.7% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$1.82 – $1.97 USDOct 19, 2026
Volume
90,430 sharesOct 19, 2026
Market value
$39.55M USDAt the close on Oct 19, 2026 · price × 21.04M shares outstanding
Grace Therapeutics, Inc. logo
Ticker
NASDAQ:GRCE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Acasti Pharma, Inc. (ACST) Q3 2023 Earnings Call

    Tue, Feb 14, 2023 · 1:00 PM ET

    Watch Transcript

  • Acasti Pharma, Inc. (ACST) Q2 2023 Earnings Call

    Mon, Nov 14, 2022 · 1:00 PM ET

    Watch Transcript

  • Acasti Pharma, Inc. (ACST) Q1 2023 Earnings Call

    Thu, Aug 11, 2022 · 1:00 PM ET

    Watch Transcript

Latest news

Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference

Sep 3, 2026

Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update

Aug 13, 2026

Grace Therapeutics Announces $10 Million Private Placement

Aug 4, 2026

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

Jul 28, 2026

Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update

Jun 18, 2026

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

Apr 23, 2026

Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026

Apr 14, 2026

Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences

Mar 19, 2026

Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

Feb 25, 2026

Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update

Feb 12, 2026

All Grace Therapeutics, Inc. news

Financings

  • Private placement of private placement financing

    Aug 13, 2026

    Update: about US$10M · US$2.1 a share · Craig-Hallum

    Dealers: Craig-Hallum (lead)

    Use of proceeds: Support the manufacturing and regulatory work needed to advance GTx-104

    Announced Aug 5, 2026 · Update Aug 13, 2026

Read by 6ix AI from the company's releases

Decks

Grace Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 29 in all · newest Sep 3, 2026 · oldest 2024
Calls
6 calls with a replay · 6 with a transcript · latest Feb 14, 2023
Decks
10 decks · latest Jul 28, 2026

Where Grace Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:GRCE · Home listing · This pageNASDAQUnited StatesUSD
BOATS:GRCEBOATSUnited StatesUSD
Lang & Schwarz:A40LELLang & SchwarzGermanyEUR
Frankfurt:L8SFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Grace Therapeutics, Inc.